| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MCRI | Common Stock | Sale | $1,269,450 | -17,346 | -22% | $73.18 | 60,450 | 05 May 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | MCRI | Options / Right to Buy | 164,999 | 05 May 2021 | Common Stock | 15,000 | $60.62 | Direct | ||||||
| holding | MCRI | Options / Right to Buy | 164,999 | 05 May 2021 | Common Stock | 33,333 | Direct | F1 | ||||||
| holding | MCRI | Options / Right to Buy | 164,999 | 05 May 2021 | Common Stock | 33,333 | Direct | F2 | ||||||
| holding | MCRI | Options / Right to Buy | 164,999 | 05 May 2021 | Common Stock | 83,333 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | In 2020 Mr. Farahi was granted 33,333 stock options, as follow: (i) 13,333 stock options at $53.680 exercise price, which vest on February 1, 2023; (ii) 1,667 stock options at $47.28 exercise price, which vest on March 1, 2023; and (iii) 18,333 stock options at $44.60 exercise price, which vest on September 30, 2023. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |
| F2 | In 2019 Mr. Farahi was granted 33,333 stock options, as follow: (i) 13,334 stock options at $43.30 exercise price, which vest on February 1, 2022; (ii) 1,666 stock options at $44.31 exercise price, which vest on March 1, 2022; (iii) 6,666 stock options at $45.69 exercise price, which vest on August 1, 2022 and (v) 11,667 stock options at $44.38 exercise price, which vest on September 1, 2022. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |
| F3 | In 2018 Mr. Farahi was granted 83,333 stock options, as follow: (i) 13,333 stock options at $45.55 exercise price, which vested on February 1, 2021; (ii) 1,667 stock options at $42.46 exercise price, which vested on March 1, 2021; (iii) 50,000 stock options at $42.74 exercise price, of which 16,666 vested on May 3, 2021, 16,667 vest on May 3, 2022 and 16,667 vest on May 3, 2023; (iv) 6,667 stock options at $47.81 exercise price, which vest on August 1, 2021 and (v) 11,666 stock options at $47.05 exercise price, which vest on September 1, 2021. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |